Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference

May 8, 2024

https://www.globenewswire.com/news-release/2024/05/08/2877821/0/en/Inozyme-Pharma-to-Participate-at-the-Bank-of-America-Securities-2024-Health-Care-Conference.html

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq:INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Doug Treco, Ph.D., CEO and Chairman of Inozyme, will participate in a fireside chat at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 from 6:40-7:10pm ET / 3:40-4:10pm PT.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.